UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 32

Sortiert nach

Interferon-alpha induces circulating tumor necrosis factor receptor p55 in humans

Blood, 1995-01, Vol.85 (2), p.433-435

1995

Volltextzugriff (PDF)

Interferon-α Induces Circulating Tumor Necrosis Factor Receptor p55 in Humans

Blood, 1995-01, Vol.85 (2), p.433-435

1995

Volltextzugriff (PDF)

The acute-phase protein α1-antitrypsin inhibits growth and proliferation of human early erythroid progenitor cells (burst-forming units-erythroid) and of human erythroleukemic cells (K562) in vitro by interfering with transferrin iron uptake

Blood, 1994, Vol.83 (1), p.260-268

1994

Volltextzugriff (PDF)

The Acute-Phase Protein αl-Antitrypsin Inhibits Growth and Proliferation of Human Early Erythroid Progenitor Cells (Burst-Forming Units-Erythroid)and of Human Erythroleukemic Cells (K562) In Vitro by Interfering With Transferrin Iron Uptake

Blood, 1994-01, Vol.83 (1), p.260-268

1994

Volltextzugriff (PDF)

Heterogeneous Distribution of Transferrin Receptors on Parenchymal and Nonparenchymal Liver Cells: Biochemical and Morphological Evidence

Blood, 1987-01, Vol.69 (1), p.264-270

1987

Volltextzugriff (PDF)

Transgenic mice overexpressing erythropoietin adapt to excessive erythrocytosis by regulating blood viscosity

Blood, 2003-09, Vol.102 (6), p.2278-2284

2003

Volltextzugriff (PDF)

Addition of Plerixafor Overcomes Poor Mobilization in Autologous and Allogeneic Stem Cell Grafts and Leads to Efficient and Sustained Engraftment

Blood, 2017-12, Vol.130, p.5457-5457

2017

Volltextzugriff (PDF)

Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Myelodysplastic Syndrome: Impact of Age and Conditioning

Blood, 2014-12, Vol.124 (21), p.5939-5939

2014

Volltextzugriff (PDF)

Bortezomib and Low-Dose Dexamethasone with or without Continuous Low-Dose Oral Cyclophosphamide for Primary Refractory or Relapsed Multiple Myeloma: Final Results of a National Multicenter Randomized Controlled Phase III Study

Blood, 2014-12, Vol.124 (21), p.3470-3470

2014

Volltextzugriff (PDF)

Disease and Therapy Associated Complications of the Central Nervous System after Allogeneic Hematopoietic Cell Transplantation - a Significant Proportion of Patients Will Suffer from Permanent Damage

Blood, 2016-12, Vol.128 (22), p.4620-4620

2016

Volltextzugriff (PDF)

Haploidentical TCRab Depleted Hematopoietic Cell Transplantation Leads To Rapid Immune Reconstitution and Promising Clinical Outcome In Adults

Blood, 2013-11, Vol.122 (21), p.5475-5475

2013

Volltextzugriff (PDF)

Haploidentical Transplantation As Salvage Therapy For Disease Relapse After Allogeneic Hematopoietic Cell Transplantation

Blood, 2013-11, Vol.122 (21), p.2084-2084

2013

Volltextzugriff (PDF)

Allogeneic Hematopoietic Cell Transplantation For Patients With Primary and Secondary Myelofibrosis: Report Of a Single Center Experience

Blood, 2013-11, Vol.122 (21), p.4538-4538

2013

Volltextzugriff (PDF)

Central Nervous System Complications After Allogeneic Hematopoietic Cell Transplantation – Treatment Related Morbidity, Toxicity, Graft Versus Host Disease Or New Autoimmunity

Blood, 2013-11, Vol.122 (21), p.2069-2069

2013

Volltextzugriff (PDF)

Reduced-Intensity Conditioning with Fludarabine and Busulfan: Age Has No Negative Impact On Survival

Blood, 2012-11, Vol.120 (21), p.2041-2041

2012

Volltextzugriff (PDF)

Delayed Immune Reconstitution After Allogeneic Hematopoietic Cell Transplantation with Yttrium-90 Ibritumomab Tiuxetan-Based Reduced-Intensity Conditioning

Blood, 2012-11, Vol.120 (21), p.4482-4482

2012

Volltextzugriff (PDF)

CD34 Selected Stem Cells Boosts Are Safe and Effective for Patients with Poor Bone Marrow Function After Allogeneic Hematopoietic Cell Transplantation

Blood, 2012-11, Vol.120 (21), p.3078-3078

2012

Volltextzugriff (PDF)

Development of New Autoimmunity Against T Cell Antigens Derived From Retinal Proteins After Allogeneic Hematopoietic Cell Transplantation

Blood, 2012-11, Vol.120 (21), p.3060-3060

2012

Volltextzugriff (PDF)

Results of Second or Third Allogeneic Hematopoietic Cell Transplantation As Salvage Therapy for Patients Failing Primary Transplantation

Blood, 2011-11, Vol.118 (21), p.4516-4516

2011

Volltextzugriff (PDF)

Allogeneic Hematopoietic Cell Transplantation with FLAMSA-RIC Can Overcome the Poor Prognosis of Primary Refractory or Relapsed AML

Blood, 2011-11, Vol.118 (21), p.1938-1938

2011

Volltextzugriff (PDF)

Impact of Donor Source and Match on Outcome of Allogeneic Hematopoietic Cell Transplantation with Reduced Intensity Conditioning

Blood, 2010-11, Vol.116 (21), p.3539-3539

2010

Volltextzugriff (PDF)

Outcome of Patients Aged ≥60 After Allogeneic Hematopoietec Cell Transplantation: Age Has No Impact on Survival

Blood, 2010-11, Vol.116 (21), p.3540-3540

2010

Volltextzugriff (PDF)

Allogeneic Hematopoietic Cell Transplantation in AML: Comparable Results After Matched or Mismatched Unrelated Versus Matched Related Transplantation

Blood, 2009-11, Vol.114 (22), p.1199-1199

2009

Volltextzugriff (PDF)

Immune Reconstitution after Haploidentical Hematopoietic Cell Transplantation: Impact of Reduced Intensity Conditioning and CD3/CD19-Depleted Grafts

Blood, 2008-11, Vol.112 (11), p.1175-1175

2008

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieBlood

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(32)

Sprache

Englisch
(32)
Japanisch
(1)

Erscheinungsjahr

n.n

Kollektion

Menü

Weitere Dienste

Einstellungen

Interferon-alpha induces circulating tumor necrosis factor receptor p55 in humans

Interferon-α Induces Circulating Tumor Necrosis Factor Receptor p55 in Humans

The acute-phase protein α1-antitrypsin inhibits growth and proliferation of human early erythroid progenitor cells (burst-forming units-erythroid) and of human erythroleukemic cells (K562) in vitro by interfering with transferrin iron uptake

The Acute-Phase Protein αl-Antitrypsin Inhibits Growth and Proliferation of Human Early Erythroid Progenitor Cells (Burst-Forming Units-Erythroid)and of Human Erythroleukemic Cells (K562) In Vitro by Interfering With Transferrin Iron Uptake

Heterogeneous Distribution of Transferrin Receptors on Parenchymal and Nonparenchymal Liver Cells: Biochemical and Morphological Evidence

Transgenic mice overexpressing erythropoietin adapt to excessive erythrocytosis by regulating blood viscosity

Addition of Plerixafor Overcomes Poor Mobilization in Autologous and Allogeneic Stem Cell Grafts and Leads to Efficient and Sustained Engraftment

Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan as part of a reduced- intensity conditioning regimen for allogeneic hematopoietic cell transplantation in patients with advanced non-Hodgkin lymphoma: results of a phase 2 study

Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Myelodysplastic Syndrome: Impact of Age and Conditioning

Bortezomib and Low-Dose Dexamethasone with or without Continuous Low-Dose Oral Cyclophosphamide for Primary Refractory or Relapsed Multiple Myeloma: Final Results of a National Multicenter Randomized Controlled Phase III Study

Disease and Therapy Associated Complications of the Central Nervous System after Allogeneic Hematopoietic Cell Transplantation - a Significant Proportion of Patients Will Suffer from Permanent Damage

Haploidentical TCRab Depleted Hematopoietic Cell Transplantation Leads To Rapid Immune Reconstitution and Promising Clinical Outcome In Adults

Haploidentical Transplantation As Salvage Therapy For Disease Relapse After Allogeneic Hematopoietic Cell Transplantation

Allogeneic Hematopoietic Cell Transplantation For Patients With Primary and Secondary Myelofibrosis: Report Of a Single Center Experience

Central Nervous System Complications After Allogeneic Hematopoietic Cell Transplantation – Treatment Related Morbidity, Toxicity, Graft Versus Host Disease Or New Autoimmunity

Reduced-Intensity Conditioning with Fludarabine and Busulfan: Age Has No Negative Impact On Survival

Delayed Immune Reconstitution After Allogeneic Hematopoietic Cell Transplantation with Yttrium-90 Ibritumomab Tiuxetan-Based Reduced-Intensity Conditioning

CD34 Selected Stem Cells Boosts Are Safe and Effective for Patients with Poor Bone Marrow Function After Allogeneic Hematopoietic Cell Transplantation

Development of New Autoimmunity Against T Cell Antigens Derived From Retinal Proteins After Allogeneic Hematopoietic Cell Transplantation

Results of Second or Third Allogeneic Hematopoietic Cell Transplantation As Salvage Therapy for Patients Failing Primary Transplantation

Allogeneic Hematopoietic Cell Transplantation with FLAMSA-RIC Can Overcome the Poor Prognosis of Primary Refractory or Relapsed AML

Impact of Donor Source and Match on Outcome of Allogeneic Hematopoietic Cell Transplantation with Reduced Intensity Conditioning

Outcome of Patients Aged ≥60 After Allogeneic Hematopoietec Cell Transplantation: Age Has No Impact on Survival

Allogeneic Hematopoietic Cell Transplantation in AML: Comparable Results After Matched or Mismatched Unrelated Versus Matched Related Transplantation

Immune Reconstitution after Haploidentical Hematopoietic Cell Transplantation: Impact of Reduced Intensity Conditioning and CD3/CD19-Depleted Grafts

Aktive Filter

Suchergebnisse filtern